Yahoo
    Shanghai - Delayed Quote CNY

    Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)

    15.03 -0.27 (-1.76%)
    At close: 3:00:00 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 603456.SS
    • Previous Close 15.30
    • Open 15.20
    • Bid 15.03 x --
    • Ask 15.04 x --
    • Day's Range 14.81 - 15.25
    • 52 Week Range 12.05 - 22.25
    • Volume 13,641,000
    • Avg. Volume 26,716,224
    • Market Cap (intraday) 13.159B
    • Beta (5Y Monthly) 0.20
    • PE Ratio (TTM) 22.43
    • EPS (TTM) 0.67
    • Earnings Date --
    • Forward Dividend & Yield 0.20 (1.31%)
    • Ex-Dividend Date Sep 11, 2026
    • 1y Target Est 19.19

    Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

    www.jiuzhoupharma.com

    4,791

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Zhejiang Jiuzhou Pharmaceutical Co., Ltd

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    603456.SS
    14.79%
    SSE Composite Index (000001.SS)
    9.09%

    1-Year Return

    603456.SS
    24.71%
    SSE Composite Index (000001.SS)
    9.26%

    3-Year Return

    603456.SS
    42.01%
    SSE Composite Index (000001.SS)
    19.05%

    5-Year Return

    603456.SS
    64.76%
    SSE Composite Index (000001.SS)
    3.13%

    Earnings Trends

    View More

    Earnings Per Share (GAAP)

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q3 FY24
    Revenue --
    Earnings 155.89M
    Profit Margin 0.00%

    Q3

    FY24

    0
    50M
    100M
    150M
    0.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    15.00
    19.19 Average
    15.03 Current
    23.00 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      11.34%

    • Return on Assets (ttm)

      5.18%

    • Return on Equity (ttm)

      6.59%

    • Revenue (ttm)

      5.28B

    • Net Income Avi to Common (ttm)

      599.2M

    • Diluted EPS (ttm)

      0.67

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      1.34B

    • Total Debt/Equity (mrq)

      0.14%

    • Levered Free Cash Flow (ttm)

      -1.14B

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    603127.SS Joinn Laboratories(China)Co.,Ltd.
    40.09 -9.85%
    603882.SS Guangzhou Kingmed Diagnostics Group Co., Ltd.
    27.72 -3.48%
    603707.SS Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
    8.20 +0.37%
    300363.SZ Porton Pharma Solutions Ltd.
    22.44 -2.90%
    603520.SS Zhejiang Starry Pharmaceutical Co.,Ltd.
    8.08 +1.25%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: